Dolby Laboratories Inc. (DLB) Tops Q2 EPS by 16c; Guides Above
Tweet
Share
E-mailGet Alerts DLB Hot Sheet
Price: $52.64 --0%
Revenue Growth %: -1.3%
Financial Fact:
Cost of licensing: 8.48M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Revenue Growth %: -1.3%
Financial Fact:
Cost of licensing: 8.48M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Dolby Laboratories Inc. (NYSE: DLB) reported Q2 EPS of $0.91, $0.16 better than the analyst estimate of $0.75. Revenue for the quarter came in at $260.3 million versus the consensus estimate of $253.53 million.
Dolby Laboratories Inc. sees FY2012 EPS of $2.80-$3.04, versus the consensus of $2.57. Dolby Laboratories Inc. sees FY2012 revenue of $910-$960 million, versus the consensus of $942 million.
For earnings history and earnings-related data on Dolby Laboratories Inc. (DLB) click here.
Dolby Laboratories Inc. sees FY2012 EPS of $2.80-$3.04, versus the consensus of $2.57. Dolby Laboratories Inc. sees FY2012 revenue of $910-$960 million, versus the consensus of $942 million.
For earnings history and earnings-related data on Dolby Laboratories Inc. (DLB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron Technology (MU) Tops Q3 EPS by $4.62, Guidance Beats
- H.B. Fuller makes £715M cash offer to acquire Advanced Medical Solutions
- Rheinmetall AG (RHM:GR) (RNMBY) PT Lowered to EUR1,750 at Morgan Stanley
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
